AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 99 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,480,106 | +89.6% | 3,052,725 | +52.2% | 0.00% | +100.0% |
| Q2 2023 | $1,835,452 | +359088.3% | 2,005,958 | +120.2% | 0.00% | – |
| Q1 2023 | $511 | -34.1% | 910,958 | -32.1% | 0.00% | – |
| Q4 2022 | $775 | -99.9% | 1,342,422 | -61.4% | 0.00% | -100.0% |
| Q3 2022 | $1,101,000 | -41.8% | 3,480,858 | -35.0% | 0.00% | 0.0% |
| Q2 2022 | $1,891,000 | -23.3% | 5,354,175 | +55.9% | 0.00% | 0.0% |
| Q1 2022 | $2,465,000 | -43.3% | 3,433,614 | +78.5% | 0.00% | -50.0% |
| Q4 2021 | $4,348,000 | +214.4% | 1,923,834 | +427.1% | 0.00% | +100.0% |
| Q2 2021 | $1,383,000 | -72.7% | 364,954 | -75.6% | 0.00% | -66.7% |
| Q1 2021 | $5,072,000 | -28.9% | 1,498,293 | -41.2% | 0.00% | -40.0% |
| Q4 2020 | $7,130,000 | +28.7% | 2,546,507 | +15.4% | 0.01% | -28.6% |
| Q3 2020 | $5,540,000 | -15.0% | 2,207,278 | +156.6% | 0.01% | -53.3% |
| Q1 2020 | $6,520,000 | +53.7% | 860,215 | +28.2% | 0.02% | +200.0% |
| Q4 2019 | $4,241,000 | +2132.1% | 671,058 | +1279.8% | 0.01% | – |
| Q3 2019 | $190,000 | -77.7% | 48,634 | -72.4% | 0.00% | -100.0% |
| Q2 2019 | $852,000 | +197.9% | 176,135 | +404.3% | 0.00% | – |
| Q1 2019 | $286,000 | -78.2% | 34,925 | -85.3% | 0.00% | -100.0% |
| Q4 2018 | $1,314,000 | -42.2% | 237,527 | -7.7% | 0.00% | -33.3% |
| Q3 2018 | $2,273,000 | -41.7% | 257,452 | -34.2% | 0.00% | -40.0% |
| Q2 2018 | $3,902,000 | -37.8% | 390,970 | -40.6% | 0.01% | -37.5% |
| Q1 2018 | $6,271,000 | -58.8% | 658,022 | -35.8% | 0.01% | -61.9% |
| Q4 2017 | $15,234,000 | -1.2% | 1,024,492 | +30.7% | 0.02% | -8.7% |
| Q3 2017 | $15,417,000 | +82.8% | 783,800 | +33.5% | 0.02% | +53.3% |
| Q2 2017 | $8,434,000 | +113.0% | 586,914 | +36.4% | 0.02% | +114.3% |
| Q1 2017 | $3,959,000 | +22.3% | 430,314 | +38.4% | 0.01% | 0.0% |
| Q4 2016 | $3,236,000 | +982.3% | 310,888 | +842.1% | 0.01% | +600.0% |
| Q3 2016 | $299,000 | -26.2% | 33,001 | -39.1% | 0.00% | 0.0% |
| Q2 2016 | $405,000 | -88.9% | 54,183 | -80.8% | 0.00% | -87.5% |
| Q4 2015 | $3,650,000 | +78.1% | 282,541 | +33.2% | 0.01% | +100.0% |
| Q3 2015 | $2,049,000 | +650.5% | 212,086 | +700.3% | 0.00% | +300.0% |
| Q2 2015 | $273,000 | +20.8% | 26,500 | +30.4% | 0.00% | – |
| Q1 2015 | $226,000 | -83.1% | 20,328 | -82.3% | 0.00% | -100.0% |
| Q4 2014 | $1,339,000 | +34.3% | 115,008 | +155.2% | 0.00% | 0.0% |
| Q3 2014 | $997,000 | – | 45,067 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |